MarketBeat
30 days ago
Stocktwits News Feed
30 days ago
MarketBeat
30 days ago
The Cerbat Gem
30 days ago
The Cerbat Gem
30 days ago
PR Newswire
30 days ago
PR Newswire
30 days ago
MarketBeat
30 days ago
MarketBeat
30 days ago
MarketBeat
30 days ago
GuruFocus
30 days ago
GuruFocus
30 days ago
GuruFocus
30 days ago
GuruFocus
30 days ago
GuruFocus
30 days ago

UWMC Investors Have Opportunity to Lead UWM Holdings Corporation Securities Fraud Lawsuit with SBS Law

GuruFocus
30 days ago

SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law

GuruFocus
30 days ago

Datavault AI Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights

GuruFocus
30 days ago

DVLT Investors Have Opportunity to Lead Datavault AI Inc. Securities Fraud Lawsuit with SBS Law

GuruFocus
30 days ago

Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights

GuruFocus
30 days ago

RXT Investors Have Opportunity to Lead Rackspace Technology, Inc. Securities Fraud Lawsuit with SBS Law

GuruFocus
30 days ago

ALAR Investors Have Opportunity to Lead Alarum Technologies Ltd. Securities Fraud Lawsuit with SBS Law

GuruFocus
30 days ago

HDFC Bank Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights

GuruFocus
30 days ago

CREATOR TV'S JOE OCHOA TO JOIN MARKETECTURE LIVE PANEL ON THE CHANGING FACE OF SPORTS FANDOM

PR Newswire
30 days ago

AbbVie Announces European Commission Approval of RINVOQ (upadacitinib) for the Treatment of Children with Active Polyarticular Juvenile Idiopathic Arthritis

PR Newswire
30 days ago

Accenture and Google Cloud Transform Software Development with Volvo Cars

PR Newswire
30 days ago

Rock Tech Lithium and Siemens Canada Sign Agreements to Bring Advanced German Engineering to Ontario Lithium Converter Project

PR Newswire
30 days ago

Zacks Research Issues Negative Forecast for CarMax Earnings

The Cerbat Gem
30 days ago

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Receives $34.36 Average Price Target from Analysts

The Cerbat Gem
30 days ago

Dimerix Wins ASX Waiver to Secure Related-Party Funding in A$50m Facility

TipRanks
30 days ago